Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. (Q33705707)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

human pregnancy

1 reference

based on heuristic

inferred from title

pregnant person

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

D. Heather Watts

7

object named as

D H Watts

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

object named as

L M Mofenson

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Y J Bryson

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

M Mirochnick

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A Stek

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

J Connor

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

E Capparelli

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

S Huang

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

M D Hughes

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

K Kaiser

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

L Purdue

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Y Asfaw

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

M Keller

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

E Smith

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PACTG 353 Team

15

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

115-125

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Nevirapine: pharmacokinetic considerations in children and pregnant women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Gender effects in pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

21 June 2018

Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study).

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

Combination antiretroviral therapy and duration of pregnancy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0902-115

21 January 2018

Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

30 October 2018

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

30 October 2018

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

30 October 2018

Risk of birth defects associated with nelfinavir exposure during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

30 October 2018

Concentrations of protease inhibitors in cord blood after in utero exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

30 October 2018

An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

30 October 2018

Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4043374

30 October 2018

https://pubmed.ncbi.nlm.nih.gov/18474496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18474496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load

1 reference

https://pubmed.ncbi.nlm.nih.gov/18474496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18474496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18474496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protease inhibitor use during pregnancy: is there an obstetrical risk?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18474496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1310/HCT0902-115

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33705707&oldid=1616503171"